Saito Biotech: Announcement on Abnormal Fluctuations in Stock Trading
Saito Biotech: Guojin Securities 2024 Semi-Annual Follow-up Report 2024 Semi-Annual Continuous Supervision and Follow-up Report
Saito Biotech: Special Report on the Storage and Use of Funds Raised for the Semi-Annual Year 2024
Saito Biotech: Announcement of Board Resolutions
Saito Biotech: Public Opinion Management System (August 2024)
Saito Biotech: Announcement of Supervisory Board Resolutions
Shandong Sito Bio-technology: Announcement Regarding Abnormal Fluctuations in Stock Trading
Shandong Sito Bio-technology: Announcement of the resolution of the fourth meeting of the fourth board of directors.
Shandong Sito Bio-technology: Announcement of the Resolution of the Fourth Meeting of the Fourth Supervisory Board.
Shandong Sito Bio-technology: LisaPharma's 2023 Annual Audit Report
Shandong Sito Bio-technology: May 10, 2024 Investor Relations Activity Schedule
Shandong Sito Bio-technology: Announcement of Supervisory Board Resolutions
Shandong Sito Bio-technology: Guojin Securities Co., Ltd.'s 2023 Continuous Supervision and Follow-up Report on Shandong Saito Biotechnology Co., Ltd.
Shandong Sito Bio-technology: Announcement on the estimated daily related transactions of the company and its subsidiaries in 2024
Shandong Sito Bio-technology: Special Audit Instructions for 2023 Non-operating Capital Occupation and Other Related Fund Transactions
Shandong Sito Bio-technology: Announcement on the company's loans to controlling shareholders and related transactions
Shandong Sito Bio-technology: Guojin Securities Co., Ltd. inspection opinions on the 2023 internal control evaluation report of Shandong Saito Biotechnology Co., Ltd.
Shandong Sito Bio-technology: Announcement of Board Resolutions
Shandong Sito Bio-technology: Independent Director's 2023 Debriefing Report (Kang Li)
Shandong Sito Bio-technology: The Board's special opinion on the sole director's independence assessment
No Data
No Data